35.36
price down icon5.33%   -1.99
after-market Dopo l'orario di chiusura: 37.20 1.84 +5.20%
loading
Precedente Chiudi:
$37.35
Aprire:
$36.31
Volume 24 ore:
2.32M
Relative Volume:
1.87
Capitalizzazione di mercato:
$7.31B
Reddito:
$29.52M
Utile/perdita netta:
$-567.06M
Rapporto P/E:
-9.6612
EPS:
-3.66
Flusso di cassa netto:
$-551.11M
1 W Prestazione:
-10.12%
1M Prestazione:
-13.21%
6M Prestazione:
-22.03%
1 anno Prestazione:
+9.71%
Intervallo 1D:
Value
$34.72
$36.77
Intervallo di 1 settimana:
Value
$34.72
$39.20
Portata 52W:
Value
$29.55
$62.40

Revolution Medicines Inc Stock (RVMD) Company Profile

Name
Nome
Revolution Medicines Inc
Name
Telefono
415-766-3638
Name
Indirizzo
700 SAGINAW DR, REDWOOD CITY, CA
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
RVMD's Discussions on Twitter

Confronta RVMD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RVMD
Revolution Medicines Inc
35.36 7.31B 29.52M -567.06M -551.11M -3.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-16 Reiterato Needham Buy
2024-07-12 Iniziato Barclays Overweight
2024-07-08 Iniziato Jefferies Buy
2024-04-12 Reiterato Needham Buy
2024-04-10 Aggiornamento Raymond James Outperform → Strong Buy
2024-03-11 Iniziato Piper Sandler Overweight
2024-01-05 Aggiornamento BofA Securities Neutral → Buy
2024-01-04 Iniziato Wedbush Outperform
2023-11-16 Iniziato Raymond James Outperform
2023-02-28 Aggiornamento JP Morgan Neutral → Overweight
2022-12-14 Iniziato Needham Buy
2022-10-21 Iniziato Oppenheimer Outperform
2022-05-20 Iniziato BofA Securities Neutral
2022-03-01 Aggiornamento Stifel Hold → Buy
2021-09-23 Iniziato Stifel Hold
2021-08-12 Downgrade Goldman Buy → Neutral
2021-05-18 Iniziato Goldman Buy
2020-05-21 Iniziato H.C. Wainwright Buy
2020-03-09 Iniziato Cowen Outperform
2020-03-09 Iniziato Guggenheim Buy
2020-03-09 Iniziato JP Morgan Neutral
Mostra tutto

Revolution Medicines Inc Borsa (RVMD) Ultime notizie

pulisher
04:43 AM

Revolution Medicines (RVMD): The Best Debt Free Mid Cap Stock to Buy Now - Yahoo Finance

04:43 AM
pulisher
04:36 AM

Revolution Medicines Brings Groundbreaking RAS Cancer Research to Major Healthcare Forums - Stock Titan

04:36 AM
pulisher
04:12 AM

Revolution Medicines to Participate in April 2025 Investor Conferences - The Manila Times

04:12 AM
pulisher
Mar 30, 2025

Is Revolution Medicines (RVMD) the Best Mid Cap Biotech Stock to Buy? - Insider Monkey

Mar 30, 2025
pulisher
Mar 24, 2025

Revolution Medicines general counsel Jeff Cislini sells $79,008 in stock By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Revolution Medicines general counsel Jeff Cislini sells $79,008 in stock - Investing.com

Mar 24, 2025
pulisher
Mar 20, 2025

Revolution Medicines executive sells shares worth $128,598 By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

Revolution Medicines’ general counsel sells $56,920 in stock By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 19, 2025

Revolution Medicines CEO Mark Goldsmith sells $458,255 in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Revolution Medicines CFO Jack Anders sells $72,771 in stock By Investing.com - Investing.com Canada

Mar 19, 2025
pulisher
Mar 19, 2025

Revolution Medicines’ general counsel sells $56,920 in stock - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Revolution Medicines CFO Jack Anders sells $72,771 in stock - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Revolution Medicines Executives Sell Shares - TradingView

Mar 19, 2025
pulisher
Mar 15, 2025

Revolution Medicines Inc (RVMD) Should Be Considered For The Next Few Weeks - Stocks Register

Mar 15, 2025
pulisher
Mar 13, 2025

Earnings To Watch: Revolution Medicines Inc (RVMD) Reports Q4 20 - GuruFocus.com

Mar 13, 2025
pulisher
Mar 13, 2025

Revolution Medicines at Leerink Conference: Expanding RAS Inhibitor Reach By Investing.com - Investing.com Canada

Mar 13, 2025
pulisher
Mar 12, 2025

Revolution Medicines’ SWOT analysis: RAS inhibitor stock shows promise amid clinical trials - Investing.com Canada

Mar 12, 2025
pulisher
Mar 12, 2025

Revolution Medicines’ SWOT analysis: RAS inhibitor stock shows promise amid clinical trials By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 11, 2025

Revolution Medicines at Barclays Conference: Focus on Pancreatic Cancer Trials - Investing.com UK

Mar 11, 2025
pulisher
Mar 06, 2025

Is Revolution Medicines, Inc. (RVMD) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey

Mar 06, 2025
pulisher
Mar 04, 2025

10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey

Mar 04, 2025
pulisher
Mar 04, 2025

Revolution Medicines’ Earnings Call: Positive Progress Amid Rising Costs - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

HC Wainwright Issues Positive Forecast for Revolution Medicines (NASDAQ:RVMD) Stock Price - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Revolution Medicines, Inc. (RVMD): Among the Cash-Rich Mid Cap Stocks to Buy Now - Yahoo Finance

Mar 03, 2025
pulisher
Mar 03, 2025

10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey

Mar 03, 2025
pulisher
Mar 02, 2025

Revolution Medicines’ (RVMD) “Outperform” Rating Reiterated at Wedbush - Armenian Reporter

Mar 02, 2025
pulisher
Mar 01, 2025

Long Term Trading Analysis for (RVMD) - Stock Traders Daily

Mar 01, 2025
pulisher
Mar 01, 2025

Wedbush Reaffirms Outperform Rating for Revolution Medicines (NASDAQ:RVMD) - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insig - GuruFocus.com

Feb 28, 2025
pulisher
Feb 27, 2025

Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus.com

Feb 27, 2025
pulisher
Feb 27, 2025

Revolution stock price target cut to $59 at Needham - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... By GuruFocus - Investing.com Canada

Feb 27, 2025
pulisher
Feb 26, 2025

Revolution Medicines Reports 2024 Financial Results and Progress - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings call transcript: Revolution Medicines Q4 2024 reflects strategic advancements - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress - GlobeNewswire

Feb 26, 2025
pulisher
Feb 26, 2025

Revolution Medicines Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2025
pulisher
Feb 26, 2025

Revolution Medicines Q4 Net Loss Narrows -February 26, 2025 at 05:13 pm EST - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings Flash (RVMD) Revolution Medicines Q4 Loss of $1.12 per Share vs. FactSet Est Loss of $0.99 - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Revolution Medicines, Inc. SEC 10-K Report - TradingView

Feb 26, 2025
pulisher
Feb 26, 2025

Can Revolution Medicines' $2.3B War Chest Overcome Mounting Losses in Cancer Drug Race? - StockTitan

Feb 26, 2025
pulisher
Feb 25, 2025

Earnings To Watch: Revolution Medicines Inc (RVMD) Reports Q4 2024 Result - Yahoo Finance

Feb 25, 2025
pulisher
Feb 24, 2025

Revolution Medicines to Participate in March 2025 Investor Conferences - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Can Revolution Medicines' Triple Conference Appearance Signal Major Clinical Updates? - StockTitan

Feb 24, 2025
pulisher
Feb 24, 2025

Rhumbline Advisers Acquires 24,473 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - Defense World

Feb 24, 2025

Revolution Medicines Inc Azioni (RVMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Capitalizzazione:     |  Volume (24 ore):